불임 치료 기기 시장 보고서 : 유형별, 환자 유형별, 최종사용자별, 지역별(2025-2033년)

The global infertility treatment devices market size reached USD 474.9 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 761.7 Million by 2033, exhibiting a growth rate (CAGR) of 5.12% during 2025-2033. The rising infertility rates, ongoing technological advancements, the growing trend of delayed parenthood, and numerous government initiatives are primarily driving the market's growth.

Infertility is a disease of the male or female reproductive system wherein attempts to achieve pregnancy after 12 months or more fail. It is generally caused by problems in the ejection of semen in the male reproductive system or abnormalities in the ovaries, uterus, fallopian tubes, and the endocrine system of the female reproductive system. It is treated using assisted reproductive technology (ART) procedures, such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), and artificial insemination methods like intrauterine insemination (IUI). At present, there is a rise in the demand for infertility treatment devices on account of the rising prevalence of conditions like polycystic ovary syndrome (PCOS) around the world.

Infertility Treatment Devices Market Trends:

The increasing number of fertility clinics across the globe represents one of the key factors propelling the growth of the market. Moreover, lack of physical activities on account of sedentary lifestyles has led to the development of chronic diseases, such as diabetes, obesity, and hypertension, which are potential risk factors leading to infertility among men and women. Consequently, there is a rise in the use of ART procedures, such as IVF, which involves the utilization of previously frozen embryos and donor eggs or sperm. This, coupled with the growing availability of numerous infertility treatment devices, is positively influencing the market. Apart from this, key players are introducing technological advancements and developing techniques that improve the conception success rate. They are also increasingly focusing on strategic developments, agreements/partnerships with domestic players, geographical expansions, and mergers and acquisitions (M&A) to increase their presence and widen their customer-base. Some of the other factors contributing to the market growth include declining fertility rates, rising public-private investments and government initiatives to increase the accessibility of infertility treatments.

Key Market Segmentation:

Breakup by Type:

• Sperm Separation Devices
• Ovum Aspiration Pumps
• Sperm Analyzer Systems
• Micromanipulator Systems
• Incubators
• Cryosystems
• Imaging Systems
• Microscopes
• Others

Breakup by Patient Type:

• Female Infertility Treatment
• Male Infertility Treatment

Breakup by End User:

• Fertility Clinics
• Hospitals and Other Healthcare Facilities
• Clinical Research Institutes

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Ab Scientific Ltd, Cook Group Incorporated, Coopersurgical Inc. (The Cooper Companies Inc.), Eppendorf, Esco Micro Pte. Ltd., Genea Limited, Hamilton Throne Ltd., Kitazato Corporation, Rocket Medical plc, Thermo Fisher Scientific, Thomas Medical (Medgyn Products Inc.), Vitrolife.

Key Questions Answered in This Report

• 1.How big is the infertility treatment devices market?
• 2.What is the future outlook of infertility treatment devices market?
• 3.What are the key factors driving the infertility treatment devices market?
• 4.Which region accounts for the largest infertility treatment devices market share?
• 5.Which are the leading companies in the global infertility treatment devices market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Infertility Treatment Devices Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Sperm Separation Devices
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Ovum Aspiration Pumps
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Sperm Analyzer Systems
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Micromanipulator Systems
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Incubators
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast
• 6.6 Cryosystems
  • 6.6.1 Market Trends
  • 6.6.2 Market Forecast
• 6.7 Imaging Systems
  • 6.7.1 Market Trends
  • 6.7.2 Market Forecast
• 6.8 Microscopes
  • 6.8.1 Market Trends
  • 6.8.2 Market Forecast
• 6.9 Others
  • 6.9.1 Market Trends
  • 6.9.2 Market Forecast

7 Market Breakup by Patient Type

• 7.1 Female Infertility Treatment
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Male Infertility Treatment
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by End User

• 8.1 Fertility Clinics
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Hospitals and Other Healthcare Facilities
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Clinical Research Institutes
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Ab Scientific Ltd
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 Cook Group Incorporated
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 Coopersurgical Inc. (The Cooper Companies Inc.)
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 Eppendorf
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 SWOT Analysis
  • 14.3.5 Esco Micro Pte. Ltd.
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 Genea Limited
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 Hamilton Throne Ltd.
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
  • 14.3.8 Kitazato Corporation
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
  • 14.3.9 Rocket Medical plc
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 Thermo Fisher Scientific
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
    • 14.3.10.4 SWOT Analysis
  • 14.3.11 Thomas Medical (Medgyn Products Inc.)
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
  • 14.3.12 Vitrolife
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio
    • 14.3.12.3 Financials